Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-11

Clinical Trial Update: Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing diagnostic accuracy and safety of DBV1605 for diagnosing non-IgE mediated cow's milk allergy in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DBV1605

Snippet

Sponsor: DBV Technologies | Conditions: Cow's Milk Allergy | Phase 2 | Status: UNKNOWN